Pharmaceutical News and Articles

Spatiotemporal Mapping IDs Four Stages of Inflammatory Bowel Disease Evolution

Machine learning has enabled spatiotemporal mapping of the four stages of the evolution of inflammatory bowel disease (IBD), according to a study published onli

FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities

Today, the U.S. Food and Drug Administration announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities that produce

Nuts, Seeds OK For People With Diverticulitis, Study Says

TUESDAY, May 6, 2025 Patients with diverticulitis often try to control the digestive condition by cutting nuts, seeds and popcorn out of their daily diet.But th

1 in 10 Doctors is Burned Out

TUESDAY, May 6, 2025 Next time you see your family physician or a hospital doctor, be extra kind and patient they could be on the verge of burning out, a new st

Follow-Up Test For High Blood Pressure Condition Not Worthwhile, Researchers Say

TUESDAY, May 6, 2025 A test commonly used to confirm a condition linked to high blood pressure is often inaccurate, causing doctors to skip treatment that might

RSV Antibody Treatment Effective For Babies

Newborns can be effectively protected against respiratory syncytial virus (RSV) infection through the use of nirsevimab, a monoclonal antibody treatment, resear

Second Opinions Don't Significantly Delay Breast Cancer Treatment

It s natural to feel a wave of anxiety following a diagnosis of breast cancer. But women shouldn t let worries about delaying treatment deter them from seeking

Teva and Alvotech Announce FDA Approval of Interchangeability for Selarsdi (ustekinumab-aekn) with Stelara (ustekinumab)

Power Outages Up Odds of Carbon Monoxide-Related ED Visits Among Children

Power outages increase the odds of carbon monoxide (CO)-related emergency department visits among children, according to a study published online May 5 in Pedia

FDA Approves SAPIEN 3 Platform for Asymptomatic Severe Aortic Stenosis

The U.S. Food and Drug Administration has approved the SAPIEN 3 platform, a transcatheter aortic valve replacement (TAVR) therapy, for patients with severe aort